Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

More On SLNCF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Silence Therapeutics plc (SLNCF)

-Other OTC
4.33 0.00(0.00%) Apr 16
Get the big picture on all your investments.
Prev Close:4.33
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.07 - 6.35
Volume:0
Avg Vol (3m):432
Market Cap:203.89M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

ยป More Headlines for SLNCF

Reports

  • No Reports available for SLNCF at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,084.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Silence Therapeutics plc, a biotechnology company, together with its subsidiaries, engages in the discovery, development, and delivery of RNA interference (RNAi) therapeutics for the treatment of serious diseases primarily in Europe and North Amer... View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback